10x Genomics, Inc. TXG Chromium — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s chromium — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s chromium — revenue?
- 10x Genomics, Inc. (TXG) reported chromium — revenue of $88.89M in Q1 2026.
- How has 10x Genomics, Inc.'s chromium — revenue changed year-over-year?
- 10x Genomics, Inc.'s chromium — revenue increased by 5.7% year-over-year, from $84.11M to $88.89M.
- What is the long-term trend for 10x Genomics, Inc.'s chromium — revenue?
- Over 3 years (2021 to 2024), 10x Genomics, Inc.'s chromium — revenue has grown at a -1.6% compound annual growth rate (CAGR), from $390.88M to $372.31M.
- What does chromium — revenue mean?
- This metric represents the total revenue generated from the sale of instruments, consumables, and software associated with the company's primary genomic analysis platform. It serves as a key indicator of the adoption and utilization rates of the core technology within the life sciences research market. Tracking this revenue stream helps investors assess the commercial performance and market penetration of the company's flagship product line.